Data / Form D filings / BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc.: Form D filings
BioRestorative Therapies, Inc., a biotechnology company in Melville, NY, filed 10 Form D notices with the SEC between 2010 and 2025. The latest, on October 9, 2025, reports $1.4 million sold of a $1.4 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 40 Marcus Drive, Suite One, Melville, NY, 11747
- Phone
- (631) 760-8100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1505497
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | New notice | $1,398,628 | $1,398,628 | 16 | Oct 8, 2025 | sec.gov | |
| May 9, 2016 | Amendment | Indefinite | $14,395,044 | 81 | Jan 14, 2014 | sec.gov | |
| Nov 25, 2015 | Amendment | Indefinite | $12,549,450 | 67 | Jan 14, 2014 | sec.gov | |
| Jan 13, 2015 | Amendment | Indefinite | $4,300,000 | 52 | Jan 14, 2014 | sec.gov | |
| Mar 26, 2014 | Amendment | $1,183,767 | $585,809 | $597,958 | 21 | Dec 2, 2013 | sec.gov |
| Mar 20, 2014 | New notice | Indefinite | $785,614 | 10 | Jan 14, 2014 | sec.gov | |
| Dec 17, 2013 | New notice | $1,183,767 | $12,000 | $1,171,767 | 2 | Dec 2, 2013 | sec.gov |
| Apr 18, 2012 | New notice | Indefinite | $1,975,000 | 6 | Apr 3, 2012 | sec.gov | |
| Mar 9, 2011 | Amendment | $3,800,000 | $1,472,500 | $2,327,500 | 15 | Nov 5, 2010 | sec.gov |
| Nov 16, 2010 | New notice | $300,000 | $135,000 | $165,000 | 6 | Nov 5, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nickolay V Kukekov | Director | |
| Robert Kristal | Executive Officer | |
| Francisco Silva | Director, Executive Officer | |
| Patrick F Williams | Director | |
| David A Rosa | Director | |
| Lance Alstodt | Director, Executive Officer |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Oct 6, 2025 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BioRestorative Therapies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.